InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ANAPTYSBIO, INC

ANAB Clue Score43
United States Fiscal year ends June CIK 0001370053 Results filed 12 May 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

16
Insider
Date
Role
Action
Shares
Price
Amount
John P. Schmid
13 Jan 2025
Director
Exercised, kept
20,645
$8.54
$176.31K
John P. Schmid
13 Jan 2025
Director
Exercised, kept
21,692
$4.55
$98.70K
Hamza Suria
17 Sep 2021
President, CEO
Exercised, kept
10,000
$1.12
$11.20K
Hamza Suria
12 May 2021
President, CEO
Exercised, kept
10,000
$1.12
$11.20K
Hamza Suria
10 Mar 2020
President, CEO
Exercised, kept
10,000
$1.12
$11.20K
Hamza Suria
5 Feb 2020
President, CEO
Exercised, kept
10,000
$1.12
$11.20K
Marco Londei
27 Nov 2019
Chief Medical Officer
Exercised, kept
46,202
$6.93
$320.18K
Hamza Suria
22 Nov 2019
President, CEO
Exercised, kept
10,000
$1.12
$11.20K
Hamza Suria
17 Apr 2019
President, CEO
Exercised, kept
10,000
$1.12
$11.20K
Marco Londei
7 Sep 2018
Chief Medical Officer
Exercised, kept
142,857
$0.70
$100.00K
Hamza Suria
9 Jul 2018
President, CEO
Exercised, kept
6,208
$1.61
$9.99K
Hamza Suria
9 Jul 2018
President, CEO
Exercised, kept
1,428
$2.24
$3.20K
Hamza Suria
8 Jun 2018
President, CEO
Exercised, kept
22,428
$2.59
$58.09K
Nicholas Lydon
15 Feb 2018
Director
Exercised, kept
16,483
$4.55
$75.00K
Frazier Healthcare V, LP
2 Feb 2017
10% owner
Exercised, kept
117,235
$4.55
$533.42K
Frazier Healthcare VII, L.P.
2 Feb 2017
10% owner
Exercised, kept indirect
117,235
$4.55
$533.42K
Show all 180 transactions →

What was left out

Form 4 filings counted 265
Amendments (4/A) skipped 1
Filings about a different issuer 1
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 68
Sales at will 66
Transactions with no price 0
Shares from compensation/vesting 22,378,949
Sales filed before the plan box existed 26
History held since 31 Jan 2017